Skip to main content
Clinical Trials/ACTRN12615001266550
ACTRN12615001266550
Completed
未知

For adults with plantar heel pain, is an ultrasound-guided corticosteroid injection more effective than foot orthoses for reducing pain and increasing function.

Glen Whittaker0 sites100 target enrollmentNovember 19, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Plantar heel pain
Sponsor
Glen Whittaker
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 19, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Glen Whittaker

Eligibility Criteria

Inclusion Criteria

  • (i)Aged 18 years and over
  • (ii)Have a clinical diagnosis of PHP in accordance with the clinical practice guidelines linked to the International Classification of Function, Disability and Health from the Orthopaedic Section of the American Physical Therapy Association, which includes:
  • a.Pain the plantar medial heel region that is aggravated by weightbearing activities or worse in the morning and/or after a period of rest
  • b.Pain upon palpation of them medial calcaneal tubercle
  • (iii)A duration of PHP for at least 4 weeks
  • (iv)Report their average pain over the last seven days as at least 30 mm on a 100 mm visual analogue scale
  • (v)Be willing to regularly wear foot orthoses for the duration of the trial
  • (vi)Be willing and have no contraindications to receive a corticosteroid injection in the plantar heel
  • (vii)Be willing not to implement any other forms of treatment during the trial (with the exception of paracetamol 4g/day)

Exclusion Criteria

  • (i)Unable to understand the English language
  • (ii)Unable to walk household distances unaided
  • (iii)Have received treatment for PHP in the last four weeks
  • (iv)Have received a corticosteroid injection in the previous six months
  • (v)Have a history of surgery to the heel
  • (vi)Have a systemic medical condition such as a connective tissue disease, degenerative neurological disorder or inflammatory disorder
  • (vii)Unwilling to wear footwear that can accommodate foot orthoses
  • (viii)Have regularly worn foot orthoses within the previous six months

Outcomes

Primary Outcomes

Not specified

Similar Trials